Dimensional Fund Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $84.9M | Sell |
425,230
-7,762
| -2% | -$1.54M | 0.02% | 1173 |
|
|
2025
Q4 | $81.9M | Sell |
432,992
-90,921
| -17% | -$17.5M | 0.02% | 1210 |
|
|
2025
Q3 | $92.8M | Sell |
523,913
-180,609
| -26% | -$26.8M | 0.02% | 1132 |
|
|
2025
Q2 | $80.1M | Sell |
704,522
-40,408
| -5% | -$4.32M | 0.02% | 1185 |
|
|
2025
Q1 | $78.3M | Buy |
744,930
+21,911
| +3% | +$2.48M | 0.02% | 1163 |
|
|
2024
Q4 | $77.5M | Buy |
723,019
+16,003
| +2% | +$1.81M | 0.02% | 1240 |
|
|
2024
Q3 | $70.8M | Sell |
707,016
-1,608
| -0.2% | -$162K | 0.02% | 1283 |
|
|
2024
Q2 | $59.7M | Buy |
708,624
+44,543
| +7% | +$3.54M | 0.02% | 1346 |
|
|
2024
Q1 | $48.5M | Buy |
664,081
+2,783
| +0.4% | +$205K | 0.01% | 1471 |
|
|
2023
Q4 | $47.2M | Buy |
661,298
+46,906
| +8% | +$2.77M | 0.01% | 1489 |
|
|
2023
Q3 | $36.8M | Buy |
614,392
+82,970
| +16% | +$5.46M | 0.01% | 1541 |
|
|
2023
Q2 | $38.3M | Buy |
531,422
+61,506
| +13% | +$4.61M | 0.01% | 1540 |
|
|
2023
Q1 | $34.6M | Buy |
469,916
+11,993
| +3% | +$853K | 0.01% | 1600 |
|
|
2022
Q4 | $30.6K | Sell |
457,923
-262,013
| -36% | -$17M | 0.01% | 1641 |
|
|
2022
Q3 | $38.7M | Buy |
719,936
+10,281
| +1% | +$604K | 0.01% | 1425 |
|
|
2022
Q2 | $39.5M | Buy |
709,655
+103,532
| +17% | +$5.88M | 0.01% | 1473 |
|
|
2022
Q1 | $42.5M | Buy |
606,123
+8,736
| +1% | +$634K | 0.01% | 1537 |
|
|
2021
Q4 | $57.6M | Sell |
597,387
-170
| -0% | -$15.7K | 0.02% | 1314 |
|
|
2021
Q3 | $51.9M | Sell |
597,557
-58,674
| -9% | -$4.54M | 0.02% | 1388 |
|
|
2021
Q2 | $53.7M | Buy |
656,231
+75,533
| +13% | +$6.28M | 0.02% | 1392 |
|
|
2021
Q1 | $55.2M | Sell |
580,698
-5,665
| -1% | -$536K | 0.02% | 1365 |
|
|
2020
Q4 | $36.4M | Sell |
586,363
-22,519
| -4% | -$1.28M | 0.01% | 1617 |
|
|
2020
Q3 | $36.2M | Sell |
608,882
-4,086
| -0.7% | -$279K | 0.02% | 1457 |
|
|
2020
Q2 | $42.8M | Sell |
612,968
-127,798
| -17% | -$8.1M | 0.02% | 1334 |
|
|
2020
Q1 | $33.6M | Sell |
740,766
-11,629
| -2% | -$659K | 0.02% | 1378 |
|
|
2019
Q4 | $49M | Buy |
752,395
+122,187
| +19% | +$8.17M | 0.02% | 1463 |
|
|
2019
Q3 | $39.1M | Buy |
630,208
+256,368
| +69% | +$16.1M | 0.02% | 1596 |
|
|
2019
Q2 | $26.6M | Buy |
373,840
+33,839
| +10% | +$2.49M | 0.01% | 1889 |
|
|
2019
Q1 | $26.7M | Buy |
340,001
+7,689
| +2% | +$583K | 0.01% | 1894 |
|
|
2018
Q4 | $28.1M | Buy |
332,312
+51,450
| +18% | +$5.48M | 0.01% | 1780 |
|
|
2018
Q3 | $48.1M | Sell |
280,862
-38,271
| -12% | -$5.77M | 0.02% | 1500 |
|
|
2018
Q2 | $41.2M | Sell |
319,133
-37,191
| -10% | -$4.15M | 0.02% | 1620 |
|
|
2018
Q1 | $36.7M | Sell |
356,324
-5,901
| -2% | -$584K | 0.02% | 1662 |
|
|
2017
Q4 | $30.9M | Sell |
362,225
-17,894
| -5% | -$1.55M | 0.01% | 1799 |
|
|
2017
Q3 | $32.3M | Sell |
380,119
-42,425
| -10% | -$3.36M | 0.01% | 1729 |
|
|
2017
Q2 | $32M | Sell |
422,544
-7,291
| -2% | -$510K | 0.01% | 1690 |
|
|
2017
Q1 | $28.4M | Sell |
429,835
-303
| -0.1% | -$19.9K | 0.01% | 1740 |
|
|
2016
Q4 | $27.3M | Sell |
430,138
-877
| -0.2% | -$55.3K | 0.01% | 1738 |
|
|
2016
Q3 | $27.4M | Sell |
431,015
-29,995
| -7% | -$2.2M | 0.01% | 1656 |
|
|
2016
Q2 | $34.3M | Sell |
461,010
-126,438
| -22% | -$9.38M | 0.02% | 1367 |
|
|
2016
Q1 | $39.2M | Sell |
587,448
-296,074
| -34% | -$18M | 0.02% | 1196 |
|
|
2015
Q4 | $59.8M | Sell |
883,522
-13,770
| -2% | -$850K | 0.04% | 692 |
|
|
2015
Q3 | $47.9M | Buy |
897,292
+13,627
| +2% | +$827K | 0.03% | 841 |
|
|
2015
Q2 | $55.6M | Buy |
883,665
+51,476
| +6% | +$2.81M | 0.03% | 761 |
|
|
2015
Q1 | $40M | Buy |
832,189
+135,116
| +19% | +$5.18M | 0.03% | 1066 |
|
|
2014
Q4 | $23.1M | Buy |
697,073
+60,514
| +10% | +$1.97M | 0.02% | 1603 |
|
|
2014
Q3 | $18.7M | Buy |
636,559
+41,144
| +7% | +$1.37M | 0.01% | 1706 |
|
|
2014
Q2 | $23.1M | Buy |
595,415
+241,203
| +68% | +$9.79M | 0.02% | 1508 |
|
|
2014
Q1 | $14.9M | Buy |
354,212
+151,133
| +74% | +$6.3M | 0.01% | 1858 |
|
|
2013
Q4 | $6.66M | Buy |
203,079
+201,715
| +14,788% | +$6.57M | 0.01% | 2428 |
|
|
2013
Q3 | $37K | Hold |
1,364
| – | – | ﹤0.01% | 3462 |
|
|
2013
Q2 | $32K | Buy |
+1,364
| New | +$24.5K | ﹤0.01% | 3464 |
|
Other funds holding LGND
VPM
VCM
NAMI
CC
Dimensional Fund Advisors's LGND Position: Q1 2026 in Review
Dimensional Fund Advisors reduced its Ligand Pharmaceuticals (LGND) stake by 1.8% in Q1 2026, selling an estimated $1.54M and leaving 425,230 shares worth $84.9M. The position accounts for 0.02% of the portfolio, ranked #1173.
Dimensional Fund Advisors first reported a position in LGND in Q2 2013 and has held it in 52 quarters since. The position peaked at $92.8M in Q3 2025. 358 funds tracked by Wall St. Rank hold LGND as of Q1 2026.
- Dimensional Fund Advisors held 425,230 shares of Ligand Pharmaceuticals worth $84.9M as of Q1 2026.
- Dimensional Fund Advisors sold 7,762 Ligand Pharmaceuticals shares in Q1 2026, an estimated $1.54M.
- Ligand Pharmaceuticals made up 0.02% of Dimensional Fund Advisors's portfolio in Q1 2026, its #1173 holding.
- Dimensional Fund Advisors first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Dimensional Fund Advisors's Ligand Pharmaceuticals position peaked at $92.8M in Q3 2025.
- 358 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.